Details of the Drug

General Information of Drug (ID: DMMYU5T)

• Drug Name: Recombinant human relaxin

Indication

Disease Entry	ICD 11	Status	REF
Scleroderma	4A42	Phase 2	[1]

• Cross-matching ID:
  PubChem CID: 71300755
  TTD ID: D0BA7K

References

• [1] ClinicalTrials.gov (NCT00406575) Recombinant Human Relaxin for the Treatment of Decompensated CHF. U.S. National Institutes of Health.